The notices it replaced
- Reissues: PAR-20-060 NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
- 2 steps back: PAR-17-154 NIDCR Prospective Observational or Biomarker Clinical Validation Study Cooperative Agreement (U01)
Replaced by PAR-25-239.
Who won it before
20 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $18,414,160 in first-year total cost, median $789,382.
Most frequent study sections
- Special Emphasis Panel[ZDE1 YM (12)]4
- Special Emphasis Panel[ZDE1 YM (07)]3
- Special Emphasis Panel[ZDE1 YM (06)]2
- Special Emphasis Panel[ZDE1 YM (11)]2
- Special Emphasis Panel[ZDE1 YM (16)]2
Most frequent institutions
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO3
- CAROLINAS MEDICAL CENTER2
- UNIVERSITY OF CALIFORNIA LOS ANGELES2
- UNIVERSITY OF MICHIGAN AT ANN ARBOR2
- WASHINGTON UNIVERSITY2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Validating the hybrid epithelial/mesenchymal state as a biomarker of treatment response and outcomes in head and neck cancer1U01DE034109-01A1 | PURAM, SIDHARTH VENKATASTOTT, SHANNON L | WASHINGTON UNIVERSITY, MO | $702,871 | ZDE1 |
| 2025 | Validation of a clinically accessible prognostic biomarker for oropharynx cancer using molecular and spatial data1U01DE034565-01 | PURAM, SIDHARTH VENKATAVIRANI, SHAMA | WASHINGTON UNIVERSITY, MO | $534,915 | ZDE1 |
| 2024 | Economic Stressors and Opportunities as Influences of Emerging Adult Oral Health1U01DE033953-01 | CHAFFEE, BENJAMIN W | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $721,722 | ZDE1 |
| 2024 | HPV-related Oropharyngeal Cancer Screening and Monitoring through Remote Self-Sampling1U01DE032997-01A1 | STURGIS, ERICH MADISON | BAYLOR COLLEGE OF MEDICINE, TX | $707,991 | ZDE1 |
| 2023 | Predicting Caries Lesion Patterns and Trajectories in Underserved Children, from Infancy to Early Adolescence, in Primary Healthcare Settings2U01DE021412-12A1 · under PAR-20-060 | FONTANA, MARGHERITA R | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $1,846,431 | ZDE1 |
| 2023 | Quantitative Imaging Biomarker Prospective Validation of Dynamic Contrast-Enhanced MRI as a Metric of Orodental Injury After Radiotherapy (QI-ProVE-MRI)1U01DE032168-01A1 · under PAR-20-060 | FULLER, CLIFTON DAVIDLAI, STEPHEN Y | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $717,338 | ZDE1 |
| 2023 | Examining impacts of structural racism and discrimination on Hispanic treatment differences and oral health disparities; known internally as "Smiles of Hope - Proyecto Hispanico de Esperanza" (SoPHE)1R56DE032675-01A1 · under PAR-20-060 | GANSKY, STUART ARAMOS-GOMEZ, FRANCISCO J.TIWARI, TAMANNA | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $572,261 | ZDE1 |
| 2022 | Susceptibility Patterns for Grade C Periodontitis in Young Individuals1U01DE031223-01A1 · under PAR-20-060 | SHADDOX, LUCIANA MACCHION | UNIVERSITY OF KENTUCKY, KY | $898,405 | ZDE1 |
| 2021 | Long-term Oral Complications of an Established Head and Neck Cancer Cohort- Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients: OraRad2U01DE022939-09 · under PAR-20-060 | BRENNAN, MICHAEL TLALLA, RAJESH V. | CAROLINAS MEDICAL CENTER, NC | $1,242,008 | ZDE1 |
| 2021 | Coordinated Oral Health Promotion (CO-OP) Chicago Cohort Study1U01DE030067-01A1 · under PAR-20-060 | MARTIN, MOLLY A | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $1,215,509 | ZDE1 |
| 2021 | Understanding Oral Diseases in Cystic Fibrosis to Develop Tailored Preventive Dental Interventions1U01DE030418-01 · under PAR-20-060 | CHI, DONALD LESLIEROSENFELD, MARGARET | UNIVERSITY OF WASHINGTON, WA | $795,360 | ZDE1 |
| 2021 | Health and Psychosocial Outcomes in Young Children with Cleft Palate1U01DE030065-01A1 · under PAR-20-060 | CRERAND, CANICE ELLEN | RESEARCH INST NATIONWIDE CHILDREN'S HOSP, OH | $775,361 | ZDE1 |
| 2020 | Velopharyngeal insufficiency following cleft palate repair: a comparative effectiveness study of existing surgical procedures and identification of criteria to guide a personalized treatment approach1U01DE029750-01 · under PAR-17-154 | SITZMAN, THOMAS JAMES | PHOENIX CHILDREN'S HOSPITAL, AZ | $842,190 | ZDE1 |
| 2020 | Observational study to validate circulating HPVDNA and prognostic genomic biomarkers for diagnosis and treatment of HPV-associated OPSCC1U01DE029754-01 · under PAR-17-154 | CHERA, BHISHAMGUPTA, GAORAV P.ISSAEVA, NATALIAYARBROUGH, WENDELL G | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $809,450 | ZDE1 |
| 2020 | Sjögren's International Collaborative Clinical Alliance Next Generation Studies (SICCA-NextGen)1U01DE028891-01A1 · under PAR-17-154 | SHIBOSKI, CAROLINE HELENE | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $807,082 | ZDE1 |
| 2020 | PROMIS oral health toolkit-supported school-based oral health program1U01DE029491-01 · under PAR-17-154 | LIU, HONGHU | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $783,404 | ZDE1 |
| 2019 | Fluoride, Dietary, and Other Factors Related to Young Adult Bone Measures and Dental Caries1U01DE028522-01 · under PAR-17-154 | LEVY, STEVEN M. | UNIVERSITY OF IOWA, IA | $341,942 | ZDE1 |
| 2019 | SjögrenâÂÂs International Collaborative Clinical Alliance Next Generation Studies (SICCA-NextGen)1R56DE028891-01 · under PAR-17-154 | CRISWELL, LINDSEY ANNSHIBOSKI, CAROLINE HELENE | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $63,700 | ZDE1 |
| 2018 | Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients (ORARAD)2U01DE022939-06A1 · under PAR-17-154 | BRENNAN, MICHAEL TLALLA, RAJESH V. | CAROLINAS MEDICAL CENTER, NC | $2,079,075 | ZDE1 |
| 2017 | Predicting Caries Risk in Underserved Children, from Toddlers to the School-Age Years, in Primary Healthcare Settings2U01DE021412-07 · under PAR-17-154 | FONTANA, MARGHERITA R | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $1,957,145 | ZDE1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.